Rational design of shepherdin, a novel anticancer agent

Cancer Cell

Volumn 7, Issue 5, 2005, Pages 457-468

  Plescia, Janet ^a   Salz, Whitney ^a   Xia, Fang ^a   Pennati, Marzia ^b   Zaffaroni, Nadia ^b   Daidone, Maria Grazia ^b   Meli, Massimiliano ^b,c   Dohi, Takehiko ^a   Fortugno, Paola ^a   Nefedova, Yulia ^d   Gabrilovich, Dmitry I ^d   Colombo, Giorgio ^c   Altieri, Dario C ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c CNR   (Italy)

^d H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; HEAT SHOCK PROTEIN 90; SHEPHERDIN; SURVIVIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BINDING AFFINITY; CELL DEATH; CELL MEMBRANE PERMEABILITY; CELL VIABILITY; COLONY FORMATION; CONTROLLED STUDY; DRUG DESIGN; DRUG TOLERABILITY; ENGINEERING; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MITOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PURIFICATION; TOXICITY; TUMOR CELL; TUMOR GROWTH;

EID: 21144437911     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2005.03.035     Document Type: Article

References (40)

1. D.C. Altieri Validating survivin as a cancer therapeutic target Nat. Rev. Cancer 3 2003 46 54
2. A.D. Basso, D.B. Solit, P.N. Munster, and N. Rosen Ansamycin antibiotics inhibit Akt activation and cyclin D expression in breast cancer cells that overexpress HER2 Oncogene 21 2002 1159 1166
3. H.M. Beere "The stress of dying": The role of heat shock proteins in the regulation of apoptosis J. Cell Sci. 117 2004 2641 2651
4. J. Brugidou, C. Legrand, J. Mery, and A. Rabie The retro-inverso form of a homeobox-derived short peptide is rapidly internalised by cultured neurones: A new basis for an efficient intracellular delivery system Biochem. Biophys. Res. Commun. 214 1995 685 693
5. Y.N. Chen, S.K. Sharma, T.M. Ramsey, L. Jiang, M.S. Martin, K. Baker, P.D. Adams, K.W. Bair, and W.G. Kaelin Jr. Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists Proc. Natl. Acad. Sci. USA 96 1999 4325 4329
6. T. Dohi, E. Beltrami, N.R. Wall, J. Plescia, and D.C. Altieri Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis J. Clin. Invest. 114 2004 1117 1127
7. P. Fortugno, E. Beltrami, J. Plescia, J. Fontana, D. Pradhan, P.C. Marchisio, W.C. Sessa, and D.C. Altieri Regulation of survivin function by Hsp90 Proc. Natl. Acad. Sci. USA 100 2003 13791 13796
8. S. Fukuda, C.R. Mantel, and L.M. Pelus Survivin regulates hematopoietic progenitor cell proliferation through p21WAF1/Cip1-dependent and -independent pathways Blood 103 2004 120 127
9. V. Guillemard, and H.U. Saragovi Novel approaches for targeted cancer therapy Curr. Cancer Drug Targets 4 2004 313 326
10. M. Herve, B. Maillere, G. Mourier, C. Texier, S. Leroy, and A. Menez On the immunogenic properties of retro-inverso peptides. Total retro-inversion of T-cell epitopes causes a loss of binding to MHC II molecules Mol. Immunol. 34 1997 157 163
11. S.E. Holt, D.L. Aisner, J. Baur, V.M. Tesmer, M. Dy, M. Ouellette, J.B. Trager, G.B. Morin, D.O. Toft, and J.W. Shay Functional requirement of p23 and Hsp90 in telomerase complexes Genes Dev. 13 1999 817 826
12. S.Y. Hong, J.E. Oh, and K.H. Lee Effect of D-amino acid substitution on the stability, the secondary structure, and the activity of membrane-active peptide Biochem. Pharmacol. 58 1999 1775 1780
13. J.S. Isaacs, W. Xu, and L. Neckers Heat shock protein 90 as a molecular target for cancer therapeutics Cancer Cell 3 2003 213 217
14. R.W. Johnstone, A.A. Ruefli, and S.W. Lowe Apoptosis: A link between cancer genetics and chemotherapy Cell 108 2002 153 164
15. P.S. Kabouridis Biological applications of protein transduction technology Trends Biotechnol. 21 2003 498 503
16. A. Kamal, L. Thao, J. Sensintaffar, L. Zhang, M.F. Boehm, L.C. Fritz, and F.J. Burrows A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors Nature 425 2003 407 410
17. Y.S. Lee, M.G. Marcu, and L. Neckers Quantum chemical calculations and mutational analysis suggest heat shock protein 90 catalyzes trans-cis isomerization of geldanamycin Chem. Biol. 11 2004 991 998
18. F. Li, G. Ambrosini, E.Y. Chu, J. Plescia, S. Tognin, P.C. Marchisio, and D.C. Altieri Control of apoptosis and mitotic spindle checkpoint by survivin Nature 396 1998 580 584
19. M.G. Marcu, A. Chadli, I. Bouhouche, M. Catelli, and L.M. Neckers The heat shock protein 90 antagonist novobiocin interacts with a previously unrecognized ATP-binding domain in the carboxyl terminus of the chaperone J. Biol. Chem. 275 2000 37181 37186
20. P. Meyer, C. Prodromou, B. Hu, C. Vaughan, S.M. Roe, B. Panaretou, P.W. Piper, and L.H. Pearl Structural and functional analysis of the middle segment of hsp90: Implications for ATP hydrolysis and client protein and cochaperone interactions Mol. Cell 11 2003 647 658
21. Y. Morishima, P.J. Murphy, D.P. Li, E.R. Sanchez, and W.B. Pratt Stepwise assembly of a glucocorticoid receptor.hsp90 heterocomplex resolves two sequential ATP-dependent events involving first hsp70 and then hsp90 in opening of the steroid binding pocket J. Biol. Chem. 275 2000 18054 18060
22. G.M. Morris, D.S. Goodsell, R.S. Halliday, R. Huey, W.E. Hart, R.K. Belew, and A.J. Olson Automated docking using a lamarckian genetic algorithm and empirical binding free energy function J Comp Chem 19 1998 1639 1662
23. S.W. Muchmore, J. Chen, C. Jakob, D. Zakula, E.D. Matayoshi, W. Wu, H. Zhang, F. Li, S.C. Ng, and D.C. Altieri Crystal structure and mutagenic analysis of the inhibitor-of-apoptosis protein survivin Mol. Cell 6 2000 173 182
24. L. Neckers, and S.P. Ivy Heat shock protein 90 Curr. Opin. Oncol. 15 2003 419 424
25. M.E. O'Dwyer, and B.J. Druker STI571: An inhibitor of the BCR-ABL tyrosine kinase for the treatment of chronic myelogenous leukaemia Lancet Oncol. 1 2000 207 211
26. H. Okada, and T.W. Mak Pathways of apoptotic and non-apoptotic death in tumour cells Nat. Rev. Cancer 4 2004 592 603
27. J.G. Paez, P.A. Janne, J.C. Lee, S. Tracy, H. Greulich, S. Gabriel, P. Herman, F.J. Kaye, N. Lindeman, and T.J. Boggon EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy Science 304 2004 1497 1500
28. M.P. Pescarolo, L. Bagnasco, D. Malacarne, A. Melchiori, P. Valente, E. Millo, S. Bruno, S. Basso, and S. Parodi A retro-inverso peptide homologous to helix 1 of c-Myc is a potent and specific inhibitor of proliferation in different cellular systems FASEB J. 15 2001 31 33
29. V. Pisarev, B. Yu, R. Salup, S. Sherman, D.C. Altieri, and D.I. Gabrilovich Full-Length Dominant-Negative Survivin for Cancer Immunotherapy Clin. Cancer Res. 9 2003 6523 6533
30. S.M. Roe, M.M. Ali, P. Meyer, C.K. Vaughan, B. Panaretou, P.W. Piper, C. Prodromou, and L.H. Pearl The Mechanism of Hsp90 regulation by the protein kinase-specific cochaperone p50(cdc37) Cell 116 2004 87 98
31. E.A. Sausville, J.E. Tomaszewski, and P. Ivy Clinical development of 17-allylamino, 17-demethoxygeldanamycin Curr. Cancer Drug Targets 3 2003 377 383
32. M. Sawada, P. Hayes, and S. Matsuyama Cytoprotective membrane-permeable peptides designed from the Bax-binding domain of Ku70 Nat. Cell Biol. 5 2003 352 357
33. O.M. Sieber, K. Heinimann, and I.P. Tomlinson Genomic instability-the engine of tumorigenesis? Nat. Rev. Cancer 3 2003 701 708
34. C.E. Stebbins, A.A. Russo, C. Schneider, N. Rosen, F.U. Hartl, and N.P. Pavletich Crystal structure of an Hsp90-geldanamycin complex: Targeting of a protein chaperone by an antitumor agent Cell 89 1997 239 250
35. C. Swanton Cell-cycle targeted therapies Lancet Oncol. 5 2004 27 36
36. L.T. Vassilev, B.T. Vu, B. Graves, D. Carvajal, F. Podlaski, Z. Filipovic, N. Kong, U. Kammlott, C. Lukacs, and C. Klein In vivo activation of the p53 pathway by small-molecule antagonists of MDM2 Science 303 2004 844 848
37. M.A. Verdecia, H. Huang, E. Dutil, D.A. Kaiser, T. Hunter, and J.P. Noel Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement Nat. Struct. Biol. 7 2000 602 608
38. B. Vogelstein, and K.W. Kinzler Cancer genes and the pathways they control Nat. Med. 10 2004 789 799
39. B. Vogelstein, D. Lane, and A.J. Levine Surfing the p53 network Nature 408 2000 307 310
40. J.C. Young, I. Moarefi, and F.U. Hartl Hsp90: A specialized but essential protein-folding tool J. Cell Biol. 154 2001 267 273